CRL

NEUTRALAnalyst

Charles River Laboratories Inte

2026-08-31

Price

$288.24

-1.12%

This is the 2026-08-31 snapshot — the signals and analysis for CRL as of this single trading day.

View full CRL research hub →

Score5.6Watchlist

Signals4/8 DNA1/13 Act · 0/4 Risk

SentimentNEUTRALScore: 9

Volume1.2xvs 20d avg

Analysis

Charles River Laboratories (CRL) is demonstrating High-Conviction Price Discovery because its robust micro fundamentals are completely overpowering broader geopolitical noise. The stock's nearly 25% monthly surge is fundamentally anchored by a recent Q2 earnings beat, raised 2026 guidance, and fresh long-term EPS upgrades from analysts. Operating in a RISK_ON macro regime where credit spreads remain ultra-tight despite Middle East tensions, CRL's PERFECT_STACK and MARKET_LEADER technical signals confirm that institutions are aggressively accumulating the stock.

Fired Signals

STEADY CLIMBGOLDEN CROSSMARKET LEADERPERFECT STACKBARGAIN HUNTER

Key Takeaways

Actionable Thesis: Capitalize on CRL's High-Conviction Price Discovery, supported by raised EPS guidance, recent analyst upgrades, and dominant technical momentum.
Key Risk: The stock's high realized volatility (46.3% annualized) leaves it vulnerable to a sudden regime shift if geopolitical shocks begin to widen corporate credit spreads.
What to Watch: Maintain a strict risk-management pivot at the $234.12 level, and monitor institutional volume for sustained participation.

← Back to 2026-08-31 View Full CRL History →Yahoo Finance &nearr;